RediNews
ETFs Holding GEVA »    GEVA Historical Stock Prices »
GEVA News Video: Wed, May 6, 2015, 11:17 AM — Wednesday's ETF Movers: XBI, PIN


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Synageva BioPharma is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. Co.'s pipeline programs are enzyme replacement therapies for lysosomal storage diseases (LSDs). Co.'s lead program, sebelipase alfa, is in global Phase 3 clinical investigation for the treatment of infants, children and adults with lysosomal acid lipase deficiency, a disease that causes morbidity and mortality. In addition, Co. has several other ongoing research programs at different stages of preclinical development, including SBC-103, another enzyme replacement therapy for an LSD known as mucopolysaccharidosis type IIIB. Self directed investors in Synageva BioPharma Corp will be interested in keeping up with all Synageva BioPharma Corp news they can find, both GEVA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on GEVA. At RediNews, we simplify this task by presenting both GEVA news releases originating from Synageva BioPharma Corp itself, and GEVA news from a variety of media outlets. Visitors can browse this news online and through our GEVA RSS news feed.

GEVA News

GEVA News — Articles, Videos, & Press Releases

GEVA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

OGXI News
KND News
SMA News
KERX News
CRVL News
GHDX News
MASI News
WCG News
SEM News
VICL News

Whether you use an enterprise information portal to update a corporate relations page, or have a handmade website with investor content in it, chances are you have come across the term "RSS" — Really Simple Syndication. Web page finance website experts and novices alike are welcome to integrate any of the RediNews RSS feeds found on the stock market content pages within our website. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . Our news would be ideal paired with free stock chart and investor content, querying for the same specific stock ticker symbol presented to the user. While experience with flash and cobranded content would be ideal for integrating our news in a cool and unique way such as within a stock market ticker or stock screener feature, our feeds can also be integrated as extra links to enhance your financial portal content with dynamic stock content that updates every time there is new news tagged with the stock, giving your visitors another reason to check back to your website in the future.

GEVA News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.